Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Stemcell United Ltd. ( (AU:BP8) ) is now available.
Stemcell United Ltd., through its subsidiary BP8 Singapore, has collaborated with Singapore Polytechnic to successfully complete an R&D program for developing innovative Green Seaweed Kefir Beverages. The project resulted in two distinct beverage types: a probiotic kefir with live bacteria cultures for gut health and a postbiotic kefir with a longer shelf life. Utilizing Caulerpa lentillifera (Seagrape) extract, the beverages were refined through sensory evaluations, showcasing potential health benefits and commercial viability. This development aligns with BP8’s mission to create innovative, sustainable consumer products.
More about Stemcell United Ltd.
Current Market Cap: A$2.1M
For detailed information about BP8 stock, go to TipRanks’ Stock Analysis page.